Dr. Dylan Eldon Stentiford, MD

Dr. Stentiford practices at Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University.

Dr. Stentiford's NPI, 1134389588, was assigned on June 10, 2008. Dr. Stentiford holds Georgia license 82245.

Dr. Stentiford's primary practice is Emory University Hospital Midtown, at 550 Peachtree Street, NE, Atlanta, GA 30308 in Fulton County. The practice phone is (404) 686-2450.

Dr. Stentiford's primary practice is Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University. Dr. Stentiford is also affiliated with Emory University Hospital. The medical group on file is Emory Clinic. Dmand AI also links Dr. Stentiford to 3 more hospitals, 1 clinical lab and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stentiford practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Stentiford's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Stentiford's licenses on file in 2 states: Georgia and Massachusetts.

CMS data shows 1,066 Medicare services from Dr. Stentiford across 9 procedure codes in 2024, for 224 Medicare patients. Medicare paid $68,572 for them. Every service was in an office.

CMS counts 224 Medicare patients who saw Dr. Stentiford in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Stentiford's median patient age at 61, with 53% women.

In 2024, Dr. Stentiford wrote 10,551 Medicare Part D claims for 982 patients. 83% of them were for generic drugs. CMS names the drug for 9,584 of them, across 157 drugs with 11 or more claims each, at $1,208,560 in total drug cost. In 2023, CMS named 7,877 claims across 150 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Stentiford for performance year 2024, reported through an alternative payment model (APM). Dr. Stentiford accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stentiford as offering telehealth.

CMS Open Payments shows 1 general payment to Dr. Stentiford from 1 drug or device company in 2022. Education make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $12.